Mesothelioma | Topics

Extrapleural Pneumonectomy After Radiation Produced Durable Survival and Was Considered Safe for Malignant Pleural Mesothelioma
February 26, 2021

Data published in The Lancet Oncology investigating patients with malignant pleural mesothelioma determined that surgery for mesothelioma after radiotherapy, or SMART, can produce positive early- and long-term effects.

FDA Approves Nivolumab Plus Ipilimumab for Previously Untreated Unresectable Malignant Pleural Mesothelioma
October 02, 2020

The agency approved the first and only immunotherapy treatment as a first-line therapy for adult patients with unresectable malignant pleural mesothelioma.

Nivolumab Plus Ipilimumab Improves OS in Malignant Pleural Mesothelioma
August 10, 2020

Data from the phase 3 CheckMate-743 trial showed a statistically significant overall survival benefit for patients with previously untreated, unresectable malignant pleural mesothelioma when treated with nivolumab plus ipilimumab.